Capital Asset Advisory Services LLC Emergent Bio Solutions Inc. Transaction History

Capital Asset Advisory Services LLC

$2.01 Billion
Q4 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$50.07 - $66.05 $212,547 - $280,382	-4,245 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$56.61 - $80.46 $12,567 - $17,862	-222 Reduced 4.97%	4,245 $267,000
Q1 2021 May 13, 2021	SELL	$86.23 - $125.19 $35,957 - $52,204	-417 Reduced 8.54%	4,467 $415,000
Q4 2020 Mar 02, 2021	SELL	$79.17 - $111.47 $13,775 - $19,395	-174 Reduced 3.44%	4,884 $438,000
Q3 2020 Nov 18, 2020	SELL	$81.91 - $134.94 $17,938 - $29,551	-219 Reduced 4.15%	5,058 $523,000
Q2 2020 Aug 14, 2020	SELL	$54.33 - $89.52 $37,053 - $61,052	-682 Reduced 11.44%	5,277 $646,000
Q1 2020 May 18, 2020	SELL	$49.34 - $68.76 $12,532 - $17,465	-254 Reduced 4.09%	5,959 $484,000
Q4 2019 Feb 13, 2020	BUY	$51.21 - $59.06 $313,046 - $361,033	6,113 Added 6113.0%	6,213 $390,000
Q4 2019 Feb 12, 2020	SELL	$51.21 - $59.06 $334,350 - $385,602	-6,529 Reduced 98.49%	100 $335,000
Q3 2019 Oct 10, 2019	BUY	$40.6 - $57.2 $12,992 - $18,304	320 Added 5.07%	6,629 $347,000
Q2 2019 Jul 15, 2019	BUY	$39.92 - $53.86 $251,855 - $339,802	6,309 New	6,309 $305,000
Q1 2019 Apr 24, 2019	SELL	$48.23 - $66.16 $398,138 - $546,150	-8,255 Closed	0 $0
Q4 2018 Jan 31, 2019	SELL	$55.63 - $73.24 $25,200 - $33,177	-453 Reduced 5.2%	8,255 $489,000
Q3 2018 Jan 31, 2019	BUY	$52.05 - $66.51 $16,968 - $21,682	326 Added 3.89%	8,708 $573,000
Q2 2018 Jul 11, 2018	SELL	$48.33 - $55.64 $69,643 - $80,177	-1,441 Reduced 14.67%	8,382 $423,000
Q1 2018 May 16, 2018	SELL	$44.44 - $54.39 $15,998 - $19,580	-360 Reduced 3.54%	9,823 $517,000
Q4 2017 Jan 11, 2018	SELL	$37.77 - $47.75 $80,752 - $102,089	-2,138 Reduced 17.35%	10,183 $473,000
Q3 2017 Oct 30, 2017	BUY	$34.14 - $40.45 $420,638 - $498,384	12,321	12,321 $498,000

Others Institutions Holding EBS

# of Institutions

174

Shares Held

36.8M

Call Options Held

336K

Put Options Held

203K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $285M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Asset Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Asset Advisory Services LLC with notifications on news.

Account